UNIT 6 DQ RESPONSES 2Evidence-Based PracticeThe first two diagnoses in the presented case study are insomnia and alcohol use. This is not a surprising fact that majority of those patients who have insomnia are addicted to alcoholism. Some people consume alcohol at night to unwind or help them feel drowsy and while alcohol can act as a sedative that slows down brain activity. The research suggests alcohol consumption generally has a negative impact on sleep quality and between 35 and 70% of individuals who use alcohol have insomnia.Treatment Plan for InsomniaDiagnostic TestingThere is no specific test to diagnose insomnia. The healthcare providers perform a physical exam and ask questions to learn more about sleep problems and symptoms. The key information for the diagnosis of insomnia is reviewing patients’ sleep history. Actigraphy can help in diagnosing insomnia but insomnia questionnaires are more effective in making diagnosis,identification of sleep apnea, and other types of sleep disorders. Blood tests are also recommended to take a sample of blood to test for thyroid disease, low iron levels, or other conditions that can cause sleep problems.Therapeutic PlanTrazodone 50 mg daily at bedtime is recommended. Trazodone is an effective drug whichis recommended for primary (difficulty in falling asleep or maintaining the sleep cycle) as well as secondary insomnia (insomnia caused by a mental disorder). According to the study of Jaffer et al. (2017) evidence for the efficacy of trazodone has been repeatedly demonstrated for primaryinsomnia as well as secondary insomnia including for symptoms that are a result of depression and dementia. The study has also mentioned that Trazodone in low doses (50 to 150 mg/day)

You may also like...
Latest tweets:
Breathing+ by Breathing Labs has passed peer review in a randomized controlled clinical trial that was recently published in SCI Q2 journal Pediatric Pulmonology. Research done by @bezmialem Full text is available in a link here: https://www.breathinglabs.com/clinical-trials/research-breathing-labs-and-nintendo-clinical-trial-is-published-in-journal-pediatric-pulmonology-sci-q2-impact-factor-3/?fbclid=IwAR2wNhSgurdbrrf3gzOOkHthgiWfXJ1x8RWvnMhkSo6fi33QPZEGzxzd6jM
BREAKING: @breathinglabs and @Nintendo clinical trial is published in journal Pediatric Pulmonology (SCI Q2, Impact Factor > 3), full text: https://breathinglabs.com/Nintendo%20&%20Breathing%20Labs%202022 #telemedicine #telehealth #mhealth
BREATHING VR: Lately we are sourcing this VR headset for use in Breathing VR application. It allows easiest installation of both breathing+ headset cable, and USB charging cables, which is essential in professional use: https://www.banggood.com/VR-SHINECON-G5-VR-Glasses-3D-Virtual-Reality-Glasses-VR-Headset-For-iPhone-XS-11Pro-Mi10-p-1679808.html?rmmds=myorder&cur_warehouse=CN
Update: Each purchase of Breathing+ will now include three machine washable mouthpieces. Previous buyers will be supplied with those by their country representatives but will have to cover shipping costs. Please be patient while we arrange distribution. https://www.breathinglabs.com/latest-news/announcement-breathing-mouthpieces-for-clinical-and-professional-use-are-now-available/
Update: We moved servers + relocated all our games to our servers, please be patient while google reviews all that (showing unsafe website atm). Use duckduckgo or non-chromium browsers to reach our pages in the meantime. Everything ok + new product addons coming out in a month!
Registration and all functionalities at http://breathinglabs.com (and in our iOS and Android games) are fixed and fully working. If you find any issues -> [email protected]
We are back in stock with Breathing+, currently searching for VR supplier, and setting up mass production for toys and tens stimulation + in November we will be signing up new erasmus traineeships, research projects, bilateral, FP(eu), and asia-pacific ->[email protected]
BREAKING: Nintendo Co. Ltd (Japan) is implementing Breathing Games by @breathinglabs in FDA approved clinical trial for children with bronchiectasis: https://clinicaltrials.gov/ct2/show/NCT04038892
Notice to b2b partners: we are running late with some minor upgrade-> briefly running out of stock -> retail and b2b sale is closed until early october. To get a list of partners with stock to sell contact us at [email protected] Thanks, we'll go strong again in winter 💪
















